Clinical Trials Browser

INDUSTRY × uproleselan × 1 year × Clear all

NCT04839341 2025-06-27

Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05054543 2025-06-27

Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML

Phase 3 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute